News

ACP-104 is currently being evaluated in three clinical trials, all of which are being conducted in patients with schizophrenia. The first clinical trial is a placebo-controlled, single ascending-dose

Insomnia can often affect the quality of life for older people leading many to rely on commonly used tranquilizers such as benzodiazepines, known to be highly addictive. The

Human stem cells offer tremendous hope for the development of revolutionary medical treatments for a variety of human health problems including damaged muscle tissue, bone injuries and nerve

Dr Fuller Torrey, president of the Stanley Medical Research Institute in Bethesda, has found that the parasite known as Toxoplasma gondii, often found in cat droppings, can produce

Remoxy is an investigational drug in late-stage clinical development by Pain Therapeutics for the treatment of moderate-to-severe chronic pain. Under the terms of the agreement, King will make

The biotech company alleges that Roche’s Cera infringes six patents owned by the company covering erythropoietin (EPO) which forms the bases of its own anemia treatment, Epogen. Amgen

Rectogesic is a topical nitroglycerin ointment indicated for the relief of pain associated with chronic anal fissures. In September 2004, the product was approved by the UK Medicines

Ranbaxy can appeal the decision, but it will not be able to market a product made using the patented intermediate compounds unless it prevails on appeal. In response

The original agreements, signed in 1997, were related to the development, manufacturing and co-promotion rights for all human cancer applications of Insegia, including stomach, esophageal, colorectal, and pancreatic